Two Sigma Advisers
IMUX icon

Two Sigma Advisers’s Immunic IMUX Stock Holding History

Two Sigma Advisers’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,072
Closed -$10.7K – 2477
2024
Q4 		$10.7K Sell
1,072
-4,100
-79% -$51.7K ﹤0.01% 2327
2024
Q3 		$85.3K Buy
5,172
+400
+8% +$5.7K ﹤0.01% 2180
2024
Q2 		$53K Sell
4,772
-12,560
-72% -$156K ﹤0.01% 2360
2024
Q1 		$229K Buy
17,332
+2,590
+18% +$33.7K ﹤0.01% 2170
2023
Q4 		$221K Sell
14,742
-17,030
-54% -$209K ﹤0.01% 2202
2023
Q3 		$467K Sell
31,772
-9,630
-23% -$185K ﹤0.01% 1813
2023
Q2 		$1.04M Buy
41,402
+1,370
+3% +$23K ﹤0.01% 1522
2023
Q1 		$596K Sell
40,032
-16,610
-29% -$308K ﹤0.01% 1873
2022
Q4 		$793K Buy
56,642
+41,920
+285% +$1.14M ﹤0.01% 1679
2022
Q3 		$465K Buy
14,722
+270
+2% +$11.3K ﹤0.01% 1871
2022
Q2 		$501K Buy
14,452
+1,280
+10% +$82K ﹤0.01% 1923
2022
Q1 		$1.49M Sell
13,172
-2,370
-15% -$274K ﹤0.01% 1419
2021
Q4 		$1.49M Sell
15,542
-980
-6% -$88.3K ﹤0.01% 1338
2021
Q3 		$1.46M Buy
16,522
+290
+2% +$28.5K ﹤0.01% 1421
2021
Q2 		$1.99M Sell
16,232
-3,060
-16% -$423K 0.01% 1302
2021
Q1 		$3.08M Sell
19,292
-850
-4% -$144K 0.01% 1062
2020
Q4 		$3.08M Buy
20,142
+8,240
+69% +$1.48M 0.01% 1048
2020
Q3 		$2.21M Buy
+11,902
New +$1.95M 0.01% 1110
2019
Q2 		– Sell
-228
Closed -$18K – 2371
2019
Q1 		$18K Buy
228
+13
+6% +$1.14K ﹤0.01% 2258
2018
Q4 		$16K Buy
215
+180
+514% +$21.1K ﹤0.01% 2316
2018
Q3 		$4K Buy
+35
New +$91.4K ﹤0.01% 2205

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Advisers's IMUX Position: Q1 2025 in Review

Two Sigma Advisers sold out of Immunic (IMUX) in Q1 2025, closing a stake of 1,072 shares — an estimated $10.7K sold.

Two Sigma Advisers first reported a position in IMUX in Q3 2018 and held it in 21 quarters. The position peaked at $3.08M in Q4 2020. 64 funds tracked by Wall St. Rank hold IMUX as of Q1 2025.

  • Two Sigma Advisers reported no remaining Immunic position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 1,072 Immunic shares in Q1 2025, an estimated $10.7K.
  • Two Sigma Advisers first reported a position in Immunic in Q3 2018 and held it in 21 quarters.
  • Two Sigma Advisers's Immunic position peaked at $3.08M in Q4 2020.
  • 64 funds tracked by Wall St. Rank held Immunic as of Q1 2025.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.